BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 1355660)

  • 1. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
    Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
    Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
    Beck J; Niethammer D; Gekeler V
    Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
    Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
    Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
    Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
    Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
    Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V
    Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias.
    Russo D; Marie JP; Zhou DC; Faussat AM; Delmer A; Maisonneuve L; Ngoc LH; Baccarani M; Zittoun R
    Leukemia; 1994 May; 8(5):881-4. PubMed ID: 7910222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
    Beck J; Niethammer D; Gekeler V
    Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
    Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
    Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of resistance genes in acute leukemia.
    Zhou DC; Hoang-Ngoc L; Delmer A; Faussat AM; Russo D; Zittoun R; Marie JP
    Leuk Lymphoma; 1994; 13 Suppl 1():27-30. PubMed ID: 8075575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage.
    Ito Y; Tanimoto M; Kumazawa T; Okumura M; Morishima Y; Ohno R; Saito H
    Cancer; 1989 Apr; 63(8):1534-8. PubMed ID: 2564311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
    Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
    Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
    Albertioni F; Gruber A; Areström I; Vitols S
    Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
    Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
    Anticancer Res; 1992; 12(1):241-5. PubMed ID: 1314532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.
    Norris MD; Haber M; King M; Davey RA
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1435-41. PubMed ID: 2575383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.
    Keith WN; Stallard S; Brown R
    Br J Cancer; 1990 May; 61(5):712-6. PubMed ID: 1970934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.